Baseline dual elevation of fractional exhaled nitric oxide and blood eosinophils is associated with clinical remission in severe eosinophilic asthma treated with biologics: a real-world prospective study

In this real-world cohort of patients with severe eosinophilic asthma treated with biologics, concomitant baseline elevation of FeNO and blood eosinophils was associated with a higher likelihood of achieving clinical remission at 12 months.